Public Citizen: Experts Criticize New England Journal of Medicine for Conflicts of Interest, Lack of Transparency in Piece on Drug Pricing
May 20, 2022
May 20, 2022
WASHINGTON, May 20 (TNSjou)(TNSreact) -- Public Citizen issued the following news release on May 19, 2022:
An article published today in STAT News criticizes the New England Journal of Medicine (NEJM) for publishing a commentary strongly endorsing the pharmaceutical industry's perspective on drug pricing, authored by economists with drug company ties that were not adequately disclosed within the piece itself.
Last November, the NEJM published the piece, "Drug . . .
An article published today in STAT News criticizes the New England Journal of Medicine (NEJM) for publishing a commentary strongly endorsing the pharmaceutical industry's perspective on drug pricing, authored by economists with drug company ties that were not adequately disclosed within the piece itself.
Last November, the NEJM published the piece, "Drug . . .